A neo-epitope fragment of type I collagen generated by MMP activity, quantifying pathological soft tissue destruction and extracellular matrix turnover.
- Home
-
Biomarkers
Biomarkers
Active filters
Add filters (0)
15 results
C1sig
A matrix metalloproteinase-generated neo-epitope fragment of type I collagen, enabling non-invasive assessment of extracellular matrix degradation and mortality risk in cardiovascular disease.
C3F
A neo-epitope fragment of type III collagen generated by fibroblast activation protein (FAP) activity, enabling non-invasive assessment of fibroblast-driven extracellular matrix remodeling in fibrotic and oncologic conditions.
C3M
A matrix metalloproteinase-generated fragment of type III collagen, reflecting extracellular matrix remodeling and enabling assessment of fibrotic activity.
C4M
A neo-epitope fragment of type IV collagen generated by matrix metalloproteinase activity, enabling non-invasive assessment of basement membrane degradation and extracellular matrix remodeling in chronic inflammatory and fibrotic diseases.
CAN (Canstatin)
Canstatin, released NC1 domain of type IV collagen a2 chain, enabling non-invasive monitoring of angiogenesis and extracellular matrix remodeling in pathological conditions such as cancer and fibrotic diseases.
CTX-III (nordicCTX-III™)
A cross-linked fragment of type III collagen generated by matrix metalloproteinase activity, enabling non-invasive assessment of fibrolysis and fibrosis resolution.
Elecsys PRO-C3® (automated)
A neo-epitope fragment of type III collagen released during extracellular matrix remodeling, enabling non-invasive quantification of active fibrogenesis and dynamic assessment of fibrosis progression and treatment response. Elecsys automated version: An in vitro diagnostic (IVD)-labelled assay developed in collaboration with Roche Diagnostics. It is intended for clinical use under regulated conditions.
Endotrophin (nordicEndotrophin™)
A bioactive fragment of type VI collagen known as Endotrophin quantifying the intact 77-amino-acid Endotrophin signaling hormone, enabling non-invasive quantification of fibro-inflammatory signaling and risk stratification in chronic disease and oncology.
NordicPRO-C3™ (Kit in a Box)
A neo-epitope fragment of type III collagen released during extracellular matrix remodeling, enabling non-invasive quantification of active fibrogenesis and dynamic assessment of fibrosis progression and treatment response. Manual ELISA kit version: The kit is FOR RESEARCH USE ONLY (RUO) and can only be used in NON-CLINICAL settings. It can not be used IN DIAGNOSTIC PROCEDURES. […]
